Cargando…
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
BACKGROUND: Identification of targetable EML4-ALK fusion proteins has revolutionized the treatment of a minor subgroup of non-small cell lung cancer (NSCLC) patients. Although fluorescence in situ hybridization (FISH) is regarded as the gold standard for detection of ALK rearrangements, ALK immunohi...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974795/ https://www.ncbi.nlm.nih.gov/pubmed/27495736 http://dx.doi.org/10.1186/s12885-016-2646-x |
_version_ | 1782446613086601216 |
---|---|
author | Mattsson, Johanna S. M. Brunnström, Hans Jabs, Verena Edlund, Karolina Jirström, Karin Mindus, Stephanie la Fleur, Linnéa Pontén, Fredrik Karlsson, Mats G. Karlsson, Christina Koyi, Hirsh Brandén, Eva Botling, Johan Helenius, Gisela Micke, Patrick Svensson, Maria A. |
author_facet | Mattsson, Johanna S. M. Brunnström, Hans Jabs, Verena Edlund, Karolina Jirström, Karin Mindus, Stephanie la Fleur, Linnéa Pontén, Fredrik Karlsson, Mats G. Karlsson, Christina Koyi, Hirsh Brandén, Eva Botling, Johan Helenius, Gisela Micke, Patrick Svensson, Maria A. |
author_sort | Mattsson, Johanna S. M. |
collection | PubMed |
description | BACKGROUND: Identification of targetable EML4-ALK fusion proteins has revolutionized the treatment of a minor subgroup of non-small cell lung cancer (NSCLC) patients. Although fluorescence in situ hybridization (FISH) is regarded as the gold standard for detection of ALK rearrangements, ALK immunohistochemistry (IHC) is often used as screening tool in clinical practice. In order to unbiasedly analyze the diagnostic impact of such a screening strategy, we compared ALK IHC with ALK FISH in three large representative Swedish NSCLC cohorts incorporating clinical parameters and gene expression data. METHODS: ALK rearrangements were detected using FISH on tissue microarrays (TMAs), including tissue from 851 NSCLC patients. In parallel, ALK protein expression was detected using IHC, applying the antibody clone D5F3 with two different protocols (the FDA approved Ventana CDx assay and our in house Dako IHC protocol). Gene expression microarray data (Affymetrix) was available for 194 patients. RESULTS: ALK rearrangements were detected in 1.7 % in the complete cohort and 2.0 % in the non-squamous cell carcinoma subgroup. ALK protein expression was observed in 1.8 and 1.4 % when applying the Ventana assay or the in house Dako protocol, respectively. The specificity and accuracy of IHC was high (> 98 %), while the sensitivity was between 69 % (Ventana) and 62 % (in house Dako protocol). Furthermore, only 67 % of the ALK IHC positive cases were positive with both IHC assays. Gene expression analysis revealed that 6/194 (3 %) tumors showed high ALK gene expression (≥ 6 AU) and of them only three were positive by either FISH or IHC. CONCLUSION: The overall frequency of ALK rearrangements based on FISH was lower than previously reported. The sensitivity of both IHC assays was low, and the concordance between the FISH and the IHC assays poor, questioning current strategies to screen with IHC prior to FISH or completely replace FISH by IHC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2646-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4974795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49747952016-08-06 Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer Mattsson, Johanna S. M. Brunnström, Hans Jabs, Verena Edlund, Karolina Jirström, Karin Mindus, Stephanie la Fleur, Linnéa Pontén, Fredrik Karlsson, Mats G. Karlsson, Christina Koyi, Hirsh Brandén, Eva Botling, Johan Helenius, Gisela Micke, Patrick Svensson, Maria A. BMC Cancer Research Article BACKGROUND: Identification of targetable EML4-ALK fusion proteins has revolutionized the treatment of a minor subgroup of non-small cell lung cancer (NSCLC) patients. Although fluorescence in situ hybridization (FISH) is regarded as the gold standard for detection of ALK rearrangements, ALK immunohistochemistry (IHC) is often used as screening tool in clinical practice. In order to unbiasedly analyze the diagnostic impact of such a screening strategy, we compared ALK IHC with ALK FISH in three large representative Swedish NSCLC cohorts incorporating clinical parameters and gene expression data. METHODS: ALK rearrangements were detected using FISH on tissue microarrays (TMAs), including tissue from 851 NSCLC patients. In parallel, ALK protein expression was detected using IHC, applying the antibody clone D5F3 with two different protocols (the FDA approved Ventana CDx assay and our in house Dako IHC protocol). Gene expression microarray data (Affymetrix) was available for 194 patients. RESULTS: ALK rearrangements were detected in 1.7 % in the complete cohort and 2.0 % in the non-squamous cell carcinoma subgroup. ALK protein expression was observed in 1.8 and 1.4 % when applying the Ventana assay or the in house Dako protocol, respectively. The specificity and accuracy of IHC was high (> 98 %), while the sensitivity was between 69 % (Ventana) and 62 % (in house Dako protocol). Furthermore, only 67 % of the ALK IHC positive cases were positive with both IHC assays. Gene expression analysis revealed that 6/194 (3 %) tumors showed high ALK gene expression (≥ 6 AU) and of them only three were positive by either FISH or IHC. CONCLUSION: The overall frequency of ALK rearrangements based on FISH was lower than previously reported. The sensitivity of both IHC assays was low, and the concordance between the FISH and the IHC assays poor, questioning current strategies to screen with IHC prior to FISH or completely replace FISH by IHC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2646-x) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-05 /pmc/articles/PMC4974795/ /pubmed/27495736 http://dx.doi.org/10.1186/s12885-016-2646-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Mattsson, Johanna S. M. Brunnström, Hans Jabs, Verena Edlund, Karolina Jirström, Karin Mindus, Stephanie la Fleur, Linnéa Pontén, Fredrik Karlsson, Mats G. Karlsson, Christina Koyi, Hirsh Brandén, Eva Botling, Johan Helenius, Gisela Micke, Patrick Svensson, Maria A. Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer |
title | Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer |
title_full | Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer |
title_fullStr | Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer |
title_full_unstemmed | Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer |
title_short | Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer |
title_sort | inconsistent results in the analysis of alk rearrangements in non-small cell lung cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974795/ https://www.ncbi.nlm.nih.gov/pubmed/27495736 http://dx.doi.org/10.1186/s12885-016-2646-x |
work_keys_str_mv | AT mattssonjohannasm inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT brunnstromhans inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT jabsverena inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT edlundkarolina inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT jirstromkarin inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT mindusstephanie inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT lafleurlinnea inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT pontenfredrik inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT karlssonmatsg inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT karlssonchristina inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT koyihirsh inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT brandeneva inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT botlingjohan inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT heleniusgisela inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT mickepatrick inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer AT svenssonmariaa inconsistentresultsintheanalysisofalkrearrangementsinnonsmallcelllungcancer |